Tasigna was first approved by the FDA in 2007 for treatment of chronic myeloid leukemia. It is one of the most popular cancer drugs in the world with over $1.7 billion in sales in 2016. More than a dozen studies have linked this popular cancer drug to atherosclerosis, a life-threatening condition which can cause peripheral arterial disease.
Patients and doctors in the United States were never warned of the connection between Tasigna and atherosclerosis. The drug’s manufacturer, Novartis, is facing a growing number of Tasigna lawsuits alleging the company was aware of the risk for severe Tasigna side effects for several years before adding a warning to the drug’s label.
If you or a loved one took Tasigna and experienced:
You may be entitled to significant compensation from the manufacturer.
There are time deadlines to file a claim so don’t wait – act now.
Free Tasigna Legal Consultation
Thank you for submitting your information.